...in sequence data available, scientists are increas... of information that determines a protein,s functi...proteins differ, such information can also help sc...cientists at the U.S. Department of Energy,s Brook...program "to sort the informational ,wheat, from th...
...es plays a role in how our arms and legs develop a... bits of material once dismissed as genetic "junk,...Harvard University. , The research, available toda...ists understand whether bits of RNA called microRN...ment not just by strategically turning off gene ac...
...ationwide will today for the first time be able to...ch for genes that underlie a range of chronic dise...t and other common diseases have been providing bl... of a project hosted by The University of Manchest...re to study genes in chronic diseases. The project...
Other Biology News:Scientists develop protein-sequence analysis tool 2MicroRNA may have fail-safe role in limb development 2'Dating agency' boosts hunt for disease genes 2(Date:11/26/2009)...f ultrasmall transistors and more powerful compute...g nanowires are closer to reality after a key disc... the University of California at Los Angeles. , ...es with layers of different materials that are sha...cal requirement for making efficient transistors o...
(Date:11/25/2009)...-- Biotech firm Replikins Ltd., which has analyzed...ic through the prediction, outbreak, and progress ...est biochemical analysis of the virus. The new dat...") virus has dropped from its peak of 3.7 (s.d. 4....ng of 2009 to resting non-epidemic levels this wee...
(Date:11/25/2009)...re/--Formanybusinesses,2009hasbeenapainfulyear.Not...ngnetworkofexpertphysiciansspecializingexclusively...wnthenumberof physiciansinitsnetwork sinceNove...dmorephysician-ownedcenters,includingoneinPuertoRi...gicMDhasopened13newbioidenticalhormonespecialtypra...
(Date:11/25/2009)...wire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a leadi...oday that it executed,a joint venture (JV) agreeme...y Co., Ltd. (Sinovac Dalian). The JV will research...cines. Sinovac will contribute its expertise,and e...class vaccines; the,other party will bring its lan...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3...ent Results in Improvements in Physical ...AN FRANCISCO, Oct. 27 More than half of patients,...of golimumab (CNTO 148),50 mg and 100 mg, an inves...ents in the joint and skin symptoms of active psor...stained through one year.,Golimumab-treated patien...
...apeutics,(Nasdaq: FOLD ) will announce third quar... of markets on Monday, November 3, 2008. The resul...nce call and webcast that,afternoon at 5 p.m. ET.,... the conference call at,5 p.m. ET by dialing 877-4...al). A telephonic replay of the call will be avail...
...FirstCall/ -- China Medical,Technologies, Inc. (th...ed,medical device company that develops, manufactu...ucts today announced that it will report selected,... revenues, net income and,earnings per ADS for the...2Q FY2008") on November 18, 2008 and full unaudite...
Other Biology Technology:One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 2One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 3One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 4One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 5One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 6One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 7One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 8One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 9Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 3... inL10 Workstation from Caliper represents a revol...y, offering for the first time the ability to gene...ly react to changing conditions. In addition, eac... viscosity due to changes in temperature, and offe...
... Series of systems provide fast and reliable scala...s, proteomics and drug development laboratories. S...urations; Mini Workstation Series, Application Ser...cation Series systems use a revolutionary new base...
...over 20 years of experience in providing versatile...the Freedom EVO platform delivers even more flexib... future needs. Together with the new easy-to-use s...to successfully operate genomics, proteomics, and ...
...n Filter is a novel disposable spin filtration dev...f bacterial lysates in plasmid purification proced...disposable spin filtration device especially desig...in plasmid purification procedures. The neutralize...
Biology Products: